LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

YHLO Unveils Total Laboratory Automation System for Elevated Laboratory Efficiency

By LabMedica International staff writers
Posted on 05 Feb 2025
Print article
Image: The iTLA Max total laboratory automation system on display at Medlab Middle East 2025 (Photo courtesy of YHLO)
Image: The iTLA Max total laboratory automation system on display at Medlab Middle East 2025 (Photo courtesy of YHLO)

YHLO (Shenzhen, China) is presenting iTLA Max, its total laboratory automation system designed to enhance laboratory workflows and optimize performance.

YHLO's independently developed iTLA MAX laboratory automation system is designed to address practical issues in medical laboratories, integrating innovative technology into every aspect of laboratory work, from pre-analysis to analysis and post-analysis, achieving comprehensive intelligent connectivity. It plays a significant role in improving clinical laboratory testing efficiency, enhancing departmental management capabilities, and advancing the development of laboratory science. The iTLA MAX laboratory automation system is composed of units such as sampling, centrifugation, capping, rack connection, track, and output, offering unprecedented convenience and efficiency in sample processing through its intelligent and efficient modular design. The 360-degree ring light design ensures that laboratory personnel can observe the equipment's operating status from any angle, providing strong support for laboratory safety management. The waterfall-style screen design, combined with ergonomic standards, adjusts the screen height to ensure user comfort during operation. The intelligent information management system integrates multiple functions such as operation control, data processing, alarm prompts, and query statistics, providing laboratory personnel with an intuitive and convenient interface.

YHLO’s iFlash series chemiluminescence immunoassay analyzers, highly acclaimed in the industry for their exceptional accuracy and rapid processing speed, were prominently featured at the exhibition. In addition to its leading self-immunity diagnostic products, YHLO highlighted its new biochemistry-immunoassay integrated analyzer along with a comprehensive suite of over 100 testing assays. As a major player in China’s IVD industry, YHLO offers a wide array of testing solutions covering self-immunity, infectious disease, reproductive health, liver disease, respiratory conditions, and cardiovascular diagnostics, among others. The new integrated analyzer provides laboratories with more flexible testing options.

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory QC Panel
Assayed Respiratory Control Panel
New
Myeloperoxidase Assay
IDK MPO ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.